Darsh Biotech Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 1.00 M
as on 07-07-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 119.60%
(FY 2021)
- Profit 153.31%
(FY 2021)
- Ebitda 198.29%
(FY 2021)
- Net Worth 22.13%
(FY 2021)
- Total Assets 137.53%
(FY 2021)
About Darsh Biotech
The Corporate was formerly known as Amingo Organic & Ayurvedic Research Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rupeshbhai Agrawal, Poonam Agarwal, and Nareshkumar Jivrajbhai serve as directors at the Company.
- CIN/LLPIN
U01132GJ2014PTC081175
- Company No.
081175
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Darsh Biotech Private Limited offer?
Darsh Biotech Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Ayurvedic Powder and Medicinal Herbs, Herb Leaves, Cosmetics, Hair & Beauty Products, Body Powder, Herbal Powder, Moringa Leaves Powder, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Darsh Biotech?
Board Members(3)
Financial Performance and Corporate Structure Insights of Darsh Biotech.
Darsh Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 119.6% increase. The company also saw a substantial improvement in profitability, with a 153.31% increase in profit. The company's net worth Soared by an impressive increase of 22.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Darsh Biotech?
In 2021, Darsh Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Haree Star Infrastructure Private Limited
Active
10 years 2 months Nareshkumar Jivrajbhai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Darsh Biotech?
Unlock and access historical data on people associated with Darsh Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Jun 05, 2017, Darsh Biotech has raised a total of ₹ 0.9 M, with the most recent deal valued at ₹ 0.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
